Skip to content

MDMA research published in 2018

82 studies whose primary subject is MDMA were published in 2018, down from 85 in 2017. Newest first. Back to the MDMA overview

Studies

Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects

ACS Chemical Neuroscience December 27, 2018 Patrick Vizeli, Henriette E. Meyer zu Schwabedissen, Matthias E. Liechti 13 citations

Methylenedioxymethamphetamine (MDMA; ecstasy) is used recreationally and has been investigated as an adjunct to psychotherapy. Most acute effects of MDMA can be attributed to activation of the serotonin (5-hydroxytryptamine [5-HT]) system. Genetic variants, such as single-nucleotide polymorphisms (SNPs) and polymorphic regions in 5-HT system genes, may contribute to interindividual differences...

El uso de MDMA para el TEPT

December 7, 2018 Mercedes Guaia Memita Guaia

El MDMA es un potente empatógeno que actúa liberando 5-HT Fue redescubierto en la década de 1970 como un fármaco útil para reducir la ira y la hostilidad en la terapia de pareja Posteriormente comenzó a utilizarse en el ambiente de las fiestas “rave” y su nombre cambió a éxtasis Recientemente, ensayos clínicos han demostrado que posee una eficacia especial en el tratamiento del TEPT resistente...

The Use of MDMA for PTSD

December 7, 2018

MDMA is a powerful empathogen that works by releasing 5-HT It was rediscovered in the 1970s as a useful drug to break down anger and hostility in couples counseling Later it started to be used in the “rave” scene and its name was changed to ecstasy Recently, trials have shown it to have special efficacy in the treatment of PTSD that has proved resistant to conventional treatments Brain imaging...

Tafsir as Mystical Experience: Intimacy and Ecstasy in Quran Commentary

December 6, 2018 Todd Lawson

In Tafsir as Mystical Experience, Todd Lawson shows how the Quran may be engaged with for meaning and understanding, the usual goal of mystical exegesis, and also how it may be engaged with through tafsīr in a quest for spiritual or mystical experience. In this earliest of the Báb's extended works, written before his public claim to be the return of the hidden Imam, the act of reading is shown...

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Journal of Psychopharmacology December 1, 2018 Marcela Ot'Alora G, Jim Grigsby, Bruce Poulter et al. 232 citations

Posttraumatic stress disorder often does not resolve after conventional psychotherapies or pharmacotherapies. Pilot studies have reported that 3,4-methylenedioxymethamphetamine (MDMA) combined with psychotherapy reduces posttraumatic stress disorder symptoms. This pilot dose response trial assessed efficacy and safety of MDMA-assisted psychotherapy across multiple therapy teams. Twenty-eight...

DOI: 10.1177/0269881118806297 (opens in new tab) Full text (opens in new tab) Serotonin 3,4-Methylenedioxymethamphetamine MDMA Oxytocin Posttraumatic stress disorder +16

MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma

Journal of Neuroscience November 19, 2018 Anthony S. Gabay, Matthew J. Kempton, James Gilleen et al. 40 citations

Social decision-making is fundamental for successful functioning and can be affected in psychiatric illness and by serotoninergic modulation. The Prisoner's Dilemma is the archetypal paradigm to model cooperation and trust. However, the effect of serotonergic enhancement is poorly characterized, and its influence on the effect of variations in opponent behavior unknown. To address this, we...

Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis

Neuroscience & Biobehavioral Reviews November 12, 2018 Felix Müller, Raphael Brändle, Matthias E. Liechti et al. 52 citations

In this meta-analysis, we aimed to assess the evidence from neuroimaging studies for chronic alterations in the brains of MDMA users. The databases PubMed, Embase, and Web of Science were searched for studies published from inception to August 24, 2018, without any language restriction. Sixteen independent studies comprising 356 MDMA users and 311 controls were included. Of these, five studies...

GC-MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA).

Archives of Toxicology November 2018 Ana Margarida Araújo, Maria de Lourdes Bastos, Eduarda Fernandes et al.

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a well-known hepatotoxic drug. Although its toxicity has been thoroughly studied at high concentrations, there is still insufficient knowledge on possible alterations of cell function at subtoxic concentrations, which are in fact more representative concentrations of intoxication scenarios. In this study, a gas chromatography-mass...

DOI: 10.1007/s00204-018-2314-9 (opens in new tab) Full text (opens in new tab) MDMA Hepatotoxicity Metabolomics Primary mouse hepatocytes +1

Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity.

Neurotoxicity Research November 2018 Giulia Costa, Micaela Morelli, Nicola Simola

Previous studies have consistently demonstrated that the amphetamine-related drug 3,4-methylenedioxymethamphetamine (MDMA) induces dopaminergic damage in the mouse brain, and that this effect is most marked in the nigrostriatal system. Moreover, it has been suggested that the overproduction of nitric oxide (NO) may participate in the dopaminergic damage induced by MDMA. To further elucidate...

DOI: 10.1007/s12640-018-9892-4 (opens in new tab) Full text (opens in new tab) Amphetamine-related drugs Caudate-putamen Neurotoxicity

Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees.

Drug and Alcohol Review November 2018 Jodie Grigg, Monica J Barratt, Simon Lenton

The term 'double dropping' refers to a person consuming two drugs simultaneously, typically two ecstasy pills. This practice has been reported in numerous countries, including Australia; however, the prevalence and correlates of double dropping among ecstasy users is unknown. Double dropping is particularly risky when adulteration of 'ecstasy' with novel substances and higher dosages of MDMA in...

Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats.

Psychopharmacology November 2018 Quenten Highgate, Susan Schenk

3,4-Methylenedioxymethamphetamine (MDMA) preferentially increases synaptic serotonin (5HT). This response was attenuated following repeated exposure but there was recovery as a result of abstinence. Effects of abstinence on self-administration of many drugs have been documented but the impact on MDMA self-administration is unknown. This study compared the effects of abstinence on MDMA and...

Why MDMA therapy for alcohol use disorder? And why now?

Neuropharmacology November 1, 2018 Ben Sessa 61 citations

Alcohol use disorder represents a serious clinical, social and personal burden on its sufferers and a significant financial strain on society. Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. The earliest historical roots of psychedelic drug-assisted psychotherapy in the 1950s were...

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.

Psychopharmacology November 1, 2018 Alicia Danforth, Charles S. Grob, Christopher M Struble et al. 284 citations

Standard therapeutic approaches to reduce social anxiety in autistic adults have limited effectiveness. Since 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy shows promise as a treatment for other anxiety disorders, a blinded, placebo-controlled pilot study was conducted. To explore feasibility and safety of MDMA-assisted psychotherapy for reduction of social fear and avoidance...

DOI: 10.1007/s00213-018-5010-9 (opens in new tab) Full text (opens in new tab) 3,4-methylenedioxymethamphetamine Asperger’s Social anxiety MDMA-Assisted Psychotherapy: 3 +2

Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4‐fluoroamphetamine intoxication

Human Psychopharmacology: Clinical and Experimental October 25, 2018 Patrick C. Dolder, Elizabeth B. de Sousa Fernandes Perna, Natasha L. Mason et al. 6 citations

OBJECTIVES: 4-Fluoroamphetamine (4-FA) is a novel psychoactive substance with a pharmacological profile and reported subjective effects (e.g., empathy) intermediate between 3,4-methylenedioxymethamphetamine (MDMA) and amphetamine. Studies have shown that MDMA and amphetamine increase emotional empathy without affecting cognitive empathy; MDMA simultaneously leads to elevated levels of oxytocin,...

DOI: 10.1002/hup.2680 (opens in new tab) MDMA Empathy Oxytocin Placebo +4

Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions

Current Molecular Pharmacology October 15, 2018 Ricardo Jorge Dinis-Oliveira, Carolina Lança Pereira, Diana Dias Da Silva 101 citations

Background:Mescaline (3,4,5-trimethoxyphenethylamine), mainly found in the Peyote cactus (Lophophora williamsii), is one of the oldest known hallucinogenic agents that influence human and animal behavior, but its psychoactive mechanisms remain poorly understood.Objective:This article aims to fully review pharmacokinetics and pharmacodynamics of mescaline, focusing on the in vivo and in vitro...

Methylenedioxymethamphetamine (MDMA) in Psychiatry

Journal of Clinical Psychopharmacology October 10, 2018 Susan Schenk, David Newcombe 53 citations

Abstract Background For a number of mental health disorders, including posttraumatic stress disorders (PTSD), there are not many available treatment options. Recently, there has been renewed interest in the potential of methylenedioxymethamphetamine (MDMA) to restore function for patients with these disorders. The primary hypothesis is that MDMA, via prosocial effects, increases the ability of...

A Conserved Role for Serotonergic Neurotransmission in Mediating Social Behavior in Octopus.

Current Biology October 8, 2018 Eric Edsinger, Gül Dölen

Human and octopus lineages are separated by over 500 million years of evolution [1, 2] and show divergent anatomical patterns of brain organization [3, 4]. Despite these differences, growing evidence suggests that ancient neurotransmitter systems are shared across vertebrate and invertebrate species and in many cases enable overlapping functions [5]. Sociality is widespread across the animal...

Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA

Cell Discovery October 5, 2018 Chao Wei, Xiao Han, Danwei Weng et al. 83 citations

Abstract Heroin, nicotine, cocaine, and MDMA are abused by billions of people. They are believed to target midbrain dopamine neurons and/or serotonin neurons, but their effects on the dynamic neuronal activity remain unclear in behaving states. By combining cell-type-specific fiber photometry of Ca 2+ signals and intravenous drug infusion, here we show that these four drugs of abuse profoundly...

Hallucinogen persisting perception disorder: A literature review and three case reports

Journal of Addictive Diseases October 2, 2018 Valentin Yurievich Skryabin, М.а. Винникова, A. Yu. Nenastieva et al. 27 citations

The paper describes diagnostic criteria, clinical presentation and types of hallucinogen persisting perception disorder (HPPD), as well as current approaches to the treatment of this phenomenon using available scientific sources. Three case reports are also presented to demonstrate different types of this disorder. The first case report describes a 23-year old patient with a previous history of...

The role of Ecstasy (MDMA) in managing intimacy and conflict in stable relationships.

Culture, health & sexuality October 2018 Kristin M. Kostick, Jean J. Schensul

This paper discusses motivations for the use of MDMA among young adults in intimate relationships living in resource poor environments, where structural constraints limit potential for economic mobility and impact upon interpersonal relations. Drawing from in-depth interviews with men and women in intimate relationships with one or more partners, we report the range of motivations for MDMA use...